Pharmacokinetics of mycophenolic acid in the early period after kidney transplantation

被引：17

作者：

Wollenberg, K

Krumme, B

Pisarski, P

Schollmeyer, P

Kirste, G

机构：

[1] Univ Hosp Freiburg, Dept Surg, D-79106 Freiburg, Germany

[2] Univ Hosp Freiburg, Dept Med, D-79106 Freiburg, Germany

来源：

TRANSPLANTATION PROCEEDINGS | 1998年 / 30卷 / 08期

关键词：

D O I：

10.1016/S0041-1345(98)01352-9

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

引用

收藏

页码：4090 / 4091

页数：2

相关论文

共 7 条

[1] Pharmacokinetics and bioavailability of mycophenolate mofetil in healthy subjects after single-dose oral and intravenous administration
Bullingham, R
Monroe, S
Nicholls, A
Hale, M
[J]. JOURNAL OF CLINICAL PHARMACOLOGY, 1996, 36 (04) : 315 - 324
[2] Danovitch G, 1996, TRANSPLANTATION, V61, P722
[3] GRINYO J, 1995, LANCET, V345, P1321
[4] Keown P, 1996, TRANSPLANTATION, V61, P1029
[5] Drug monitoring of mycophenolic acid in the early period after renal transplantation
Krumme, B
Wollenberg, K
Kirste, G
Schollmeyer, P
[J]. TRANSPLANTATION PROCEEDINGS, 1998, 30 (05) : 1773 - 1774
[6] MYCOPHENOLATE MOFETIL - A REPORT OF THE CONSENSUS PANEL
SHAW, LM
SOLLINGER, HW
HALLORAN, P
MORRIS, RE
YATSCOFF, RW
RANSOM, J
TSINA, I
KEOWN, P
HOLT, DW
LIEBERMAN, R
JAKLITSCH, A
POTTER, J
[J]. THERAPEUTIC DRUG MONITORING, 1995, 17 (06) : 690 - 699
[7] MYCOPHENOLATE MOFETIL FOR THE PREVENTION OF ACUTE REJECTION IN PRIMARY CADAVERIC RENAL-ALLOGRAFT RECIPIENTS
SOLLINGER, HW
[J]. TRANSPLANTATION, 1995, 60 (03) : 225 - 232